IC

Dogwood Therapeutics, Inc. (DWTX)

NASDAQ: DWTX · Real-Time Price · USD

4.780

+0.220 (4.82%)

At close: May 12, 2025, 4:00 PM

4.970

+0.190 (3.97%)

After-hours: May 12, 2025, 7:55 PM EDT

Dogwood Therapeutics Employees

Dogwood Therapeutics had 12 employees as of December 31, 2024. The number of employees increased by 8 or 200.00% compared to the previous year.

Employees

12

Change (1Y)

8

Growth (1Y)

200.00%

Revenue / Employee

n/a

Profits / Employee

-$1,979,509

Market Cap

9.14M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	12	8	200.00%
Dec 31, 2023	4	0	-
Dec 31, 2022	4	-1	-20.00%
Dec 31, 2021	5	2	66.67%
Dec 31, 2020	3	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

DWTX News

4 days ago - Dogwood Therapeutics Announces First Quarter 2025 Financial Results - GlobeNewsWire
11 days ago - Dogwood Therapeutics, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference - Newsfile Corp
4 weeks ago - Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation of Compliance - GlobeNewsWire
5 weeks ago - Dogwood Therapeutics, Inc. Regains Nasdaq Compliance - GlobeNewsWire
6 weeks ago - Dogwood Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
7 weeks ago - Dogwood Therapeutics Announces Dosing of First Patient in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy-Induced Neuropathic Pain - GlobeNewsWire
2 months ago - Dogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
7 months ago - Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) - GlobeNewsWire